"Somos una institución integrada por un equipo de personas, profesionales y especialistas comprometidos con la salud y el bienestar de nuestros pacientes y la comunidad. Trabajamos en forma permanente en la mejora continua de la gestión para brindar el servicio de calidad que queremos para nuestra comunidad. Brindamos una amplia variedad de servicios en distintas especialidades con una mirada integral de la salud, a través de una atención de calidad centrada en el bienestar del paciente y su familia."

During the past decade, Clínica Viedma conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 5 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 3 clinical trials were completed. i.e. 21.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clínica Viedma" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "AVEO Pharmaceuticals, Inc." with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clínica Viedma" #1 collaborator was "Actoverco" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Clínica Viedma" are "Non-Small Cell Lung Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Neoplasm Metastasis" (2 trials). Many other conditions were trialed in "Clínica Viedma" in a lesser frequency.

Most popular intervention types in "Clínica Viedma" are "Drug" (19 trials), "Biological" (2 trials), "Device" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Carboplatin" (4 trials), "Pemetrexed" (4 trials), "Cisplatin" (3 trials) and "Lazertinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clínica Viedma" are 17 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clínica Viedma". undefined are not yet recruiting, 11 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Clínica Viedma, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clínica Viedma, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".